Search

everythinglearnresearchcommunity

for

Search:↓

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

Older age is the main risk factor for hemorrhagic cystitis after stem cell transplants.

Hamilton scale imprecise, hair shaft diameter decreases, stem cell transplant regrows hair, ECP ineffective for alopecia areata universalis.

CD19-CAR T cell therapy may help regenerate skin in systemic sclerosis.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

Adipose-derived stem cells are promising for regenerative medicine due to their accessibility, versatility, and low risk of immune rejection.

Cryotherapy helps reduce chemotherapy side effects but needs more research for best use.

Stem-cell therapy shows promise for skin conditions but needs more research.

Treating acute myeloid leukemia is challenging, especially in older adults, despite some advancements.

Donor lymphocyte infusions effectively treated leukemia relapse but caused vitiligo and alopecia areata.

The treatment was not recommended due to limited effectiveness and significant side effects.

Irradiating the whole central nervous system can lead to over 50% of patients with cerebellar medulloblastoma surviving three years.

Treatments for acute leukaemia lead to high remission rates, but relapses occur, requiring ongoing advancements in care.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Immunochemotherapy successfully treated neutropenia in a patient with Waldenström's macroglobulinemia.

Hair regrowth was achieved using 5-Fluorouracil and Bleomycin for scalp atrophy caused by corticosteroids.

Radiation therapy with a higher dose for the brain improves survival in cerebellar medulloblastoma.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

The treatment was effective for advanced non-Hodgkin's lymphomas.

Isolated hyperthermic chemotherapy perfusion for limb melanoma is safe and effective with manageable side effects.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

Isolated limb perfusion is a safe and effective treatment for limb melanoma.

Chemotherapy for leukemia led to full hair regrowth in a child with alopecia totalis.

Immunological treatment improved both neuropathy and alopecia.

Intravenous arsenic is safe and effective for treating certain blood cancers.

The treatment improved hair color in most vitiligo patients without major side effects.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.